sparfloxacin has been researched along with heptanol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armstrong, C; Dhir, V; Hickman, JJ; Molnar, P; Natarajan, A; Sommerhage, F; Stancescu, M | 1 |
Berry, BJ; Esch, MB; Hickman, JJ; Long, CJ; McAleer, C; Miller, PG; Molnar, P; Prot, JM; Shuler, ML; Smith, AS; Stancescu, M | 1 |
1 review(s) available for sparfloxacin and heptanol
Article | Year |
---|---|
Microphysiological systems and low-cost microfluidic platform with analytics.
Topics: Blood-Brain Barrier; Cell Survival; Epithelial Cells; Fluoroquinolones; Gases; Heptanol; Humans; Lung; Microfluidic Analytical Techniques; Models, Biological; Muscle, Skeletal; Myocardium | 2013 |
1 other study(ies) available for sparfloxacin and heptanol
Article | Year |
---|---|
Patterned cardiomyocytes on microelectrode arrays as a functional, high information content drug screening platform.
Topics: Action Potentials; Antitubercular Agents; Cells, Cultured; Clinical Trials as Topic; Culture Media, Serum-Free; Drug Evaluation, Preclinical; Fluoroquinolones; Heptanol; Humans; Microelectrodes; Myocytes, Cardiac | 2011 |